help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/endo-118-5-1910
Endocrinology Vol. 118, No. 5 1910-1917
Copyright © 1986 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LABURTHE, M.
Right arrow Articles by AMIRANOFF, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LABURTHE, M.
Right arrow Articles by AMIRANOFF, B.

Interaction of Peptide YY with Rat Intestinal Epithelial Plasma Membranes: Binding of the Radioiodinated Peptide

MARC LABURTHE, BERNARD CHENUT, CHRISTIANE ROUYER-FESSARD, KAZUHIKO TATEMOTO, ALAIN COUVINEAU, ALAIN SERVIN and BRIGITTE AMIRANOFF

Equipe de Recherches de Neuroendocrinologie du Système Digestif, Institut National de la Santé et de la Recherche Médicale INSERM U178, Villejuif, France
Nancy Pritziker Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine Stanford, California 94305

Address all correspondence and request for reprints to: Marc Laburthe, INSERM U178, Batiment INSERM, 16 avenue Paul Vaillant Couturier, 94807 Villejuif Cedex, France.

Abstract

High affinity binding sites for peptide YY (PYY) have been identified and characterized in plasma membranes prepared from rat jejunal epithelium by studying the kinetics, stoichiometry, and chemical specificity of the interaction of 125I-labeled PYY with membranes. Binding of [125I]PYY was rapid, saturable, reversible, specific, and depended on temperature, pH, and ionic strength. In optimized steady state conditions of binding (2 h of incubation at 15 C), the degradation of both [125I] PYY and binding sites did not exceed 20%. The concentration dependence of PYY binding, determined by adding increasing concentrations of [125I]PYY, indicated that specific binding saturated at 2–3 nM peptide. Scatchard analysis revealed a single class of binding sites with a dissociation constant (Kd) of 434 ± (SE) 56 pM and a binding capacity of 336 ± 41 fmol/mg protein (n + 11). Identical results were obtained when increasing concentrations of unlabeled PYY were added to a fixed concentration of [125I]PYY, indicating that the radioiodinated peptide has the same apparent affinity as native PYY. Peptides structurally unrelated to PYY, such as members of the vasoactive intestinal peptide family, insulin, or cholecystokinin octapeptide, were unable to compete with [125I]PYY for binding to membranes. Rat, human, and avian pancreatic polypeptides, which display, respectively, 42%, 47%, and 53% homology with PYY, did inhibit [125I]PYY binding but with an approximate or equal to 100,000-fold lower potency than PYY, indicating the strict structural requirement for recognition by PYY binding sites. In contrast, natural or synthetic neuropeptide Y, which has 25 out of 36 amino acids in common with PYY, retained a high affinity for PYY binding sites [only 4.7 ± 1.2 (n + 5) times lower than that of PYY]. Specific [125I]PYY binding was particularly high in the upper small intestine and could not be detected in stomach, large intestine, or liver. These findings indicate that rat small intestinal epithelium expresses specific binding sites for the candidate gut hormone PYY that also binds the neuropeptide Y with high affinity, suggesting that the two peptides may regulate the function of small intestinal epithelium, through interaction with a common receptor site. (Endocrinology 118: 1910–1917, 1986)

Received September 18, 1985.




This article has been cited by other articles:


Home page
Cancer Res.Home page
A. Ferrand, C. Bertrand, G. Portolan, G. Cui, J. Carlson, L. Pradayrol, D. Fourmy, M. Dufresne, T. C. Wang, and C. Seva
Signaling Pathways Associated with Colonic Mucosa Hyperproliferation in Mice Overexpressing Gastrin Precursors
Cancer Res., April 1, 2005; 65(7): 2770 - 2777.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. K. Chelikani, A. C. Haver, and R. D. Reidelberger
Intravenous Infusion of Peptide YY(3-36) Potently Inhibits Food Intake in Rats
Endocrinology, February 1, 2005; 146(2): 879 - 888.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. K. Chelikani, A. C. Haver, and R. D. Reidelberger
Comparison of the inhibitory effects of PYY(3-36) and PYY(1-36) on gastric emptying in rats
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2004; 287(5): R1064 - R1070.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Goumain, T. Voisin, A.-M. Lorinet, R. Ducroc, A. Tsocas, C. Roze, P. Rouet-Benzineb, H. Herzog, A. Balasubramaniam, and M. Laburthe
The Peptide YY-Preferring Receptor Mediating Inhibition of Small Intestinal Secretion Is a Peripheral Y2 Receptor: Pharmacological Evidence and Molecular Cloning
Mol. Pharmacol., July 1, 2001; 60(1): 124 - 134.
[Abstract] [Full Text]


Home page
GutHome page
L Ferrier, J-P Segain, P Pacaud, C Cherbut, G Loirand, J-P Galmiche, and H M Blottiere
Pathways and receptors involved in peptide YY induced contraction of rat proximal colonic muscle in vitro
Gut, March 1, 2000; 46(3): 370 - 375.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Hallden, M. Hadi, H. T. Hong, and G. W. Aponte
Y Receptor-mediated Induction of CD63 Transcripts, a Tetraspanin Determined To Be Necessary for Differentiation of the Intestinal Epithelial Cell Line, hBRIE 380i Cells
J. Biol. Chem., September 24, 1999; 274(39): 27914 - 27924.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
M. Jackerott and L.-I. Larsson
Immunocytochemical Localization of the NPY/PYY Y1 Receptor in Enteric Neurons, Endothelial Cells, and Endocrine-like Cells of the Rat Intestinal Tract
J. Histochem. Cytochem., December 1, 1997; 45(12): 1643 - 1650.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. A. Blaze, P. J. Mannon, S. R. Vigna, A. R. Kherani, and B. A. Benjamin
Peptide YY receptor distribution and subtype in the kidney: effect on renal hemodynamics and function in rats
Am J Physiol Renal Physiol, October 1, 1997; 273(4): F545 - F553.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Hallden and G. W. Aponte
Evidence for a Role of the Gut Hormone PYY in the Regulation of Intestinal Fatty Acid-binding Protein Transcripts in Differentiated Subpopulations of Intestinal Epithelial Cell Hybrids
J. Biol. Chem., May 9, 1997; 272(19): 12591 - 12600.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Voisin, A.-M. Lorinet, J.-J. Maoret, A. Couvineau, and M. Laburthe
Galpha(i) RNA Antisense Expression Demonstrates the Exclusive Coupling of Peptide YY Receptors to G[IMAGE] Proteins in Renal Proximal Tubule Cells
J. Biol. Chem., January 5, 1996; 271(1): 574 - 580.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Lundell, A. G. Blomqvist, M. M. Berglund, D. A. Schober, D. Johnson, M. A. Statnick, R. A. Gadski, D. R. Gehlert, and D. Larhammar
Cloning of a Human Receptor of the NPY Receptor Family with High Affinity for Pancreatic Polypeptide and Peptide YY
J. Biol. Chem., December 8, 1995; 270(49): 29123 - 29128.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1986 by The Endocrine Society